# SecOnd-generation seLf-expandable Versus Balloon-expandable Valves and gEneral Versus Local Anesthesia in TAVI

> **NCT02737150** · NA · UNKNOWN · sponsor: **Helios Health Institute GmbH** · enrollment: 444 (actual)

## Conditions studied

- Aortic Stenosis

## Interventions

- **DEVICE:** CoreValve Evolut R
- **DEVICE:** Edwards Sapien 3
- **PROCEDURE:** Local anesthesia with conscious sedation
- **PROCEDURE:** General anesthesia

## Key facts

- **NCT ID:** NCT02737150
- **Lead sponsor:** Helios Health Institute GmbH
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-04
- **Primary completion:** 2019-02-01
- **Final completion:** 2021-04
- **Target enrollment:** 444 (ACTUAL)
- **Last updated:** 2021-02-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02737150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02737150, "SecOnd-generation seLf-expandable Versus Balloon-expandable Valves and gEneral Versus Local Anesthesia in TAVI". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02737150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*